Table 4.
Part of Tilapia | Species | Protease Used for Hydrolysis | Sample Dose | Cell Model | Key Findings | Reference |
---|---|---|---|---|---|---|
Muscle | Oreochromis niloticus |
|
7.5–25% |
|
|
[56] |
Skin | Oreochromis niloticus | Alcalase® followed with Pronase E® | 1.56–12.5 mg/mL | AAPH-treated Detroit 551 cells |
|
[49] |
Skin | Oreochromis niloticus | Ginger protease | 0.5–10 mg/mL | H2O2-treated IPEC-J2 cells |
|
[55] |
Scales | Oreochromis sp. | Alcalase® | 2 mg/mL | Angiotensin II-treated A7r5 cells |
|
[50] |
Scales | Oreochromis niloticus | Trypsin | 50–500 µg/mL | UVA radiation-treated HFF-1 cells |
|
[51] |
Dorsal meat | Oreochromis niloticus | Alcalase® followed with pepsin and pancreatin | 0.1–5.0 mg/mL | AAPH-treated HepG2 cells |
|
[47] |
a AAPH, 2,2′-azobis(2-amidinopropane) dihydrochloride; A7r5, rat vascular smooth muscle; Detroit 551, human embryonic skin fibroblast; GSH, reduced glutathione; HepG2, human hepatocellular carcinoma; HFF-1, human foreskin fibroblast; IPEC-J2, porcine jejunal; LDH, lactate dehydrogenase; MMP, matrix metalloproteinase; O2●−, superoxide; ROS, reactive oxygen species; SOD, superoxide dismutase; UVA, ultraviolet A.